RPAM
Rhenman & Partners Asset Management’s Relay Therapeutics RLAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Hold |
460,000
| – | – | 0.2% | 77 |
|
|
2025
Q1 | $1.21M | Hold |
460,000
| – | – | 0.14% | 84 |
|
|
2024
Q4 | $1.9M | Hold |
460,000
| – | – | 0.19% | 82 |
|
|
2024
Q3 | $3.26M | Buy |
460,000
+230,000
| +100% | +$1.63M | 0.26% | 77 |
|
|
2024
Q2 | $1.5M | Hold |
230,000
| – | – | 0.14% | 81 |
|
|
2024
Q1 | $1.91M | Sell |
230,000
-160,000
| -41% | -$1.33M | 0.18% | 76 |
|
|
2023
Q4 | $4.29M | Buy |
390,000
+200,000
| +105% | +$2.2M | 0.43% | 61 |
|
|
2023
Q3 | $1.6M | Hold |
190,000
| – | – | 0.17% | 76 |
|
|
2023
Q2 | $2.39M | Hold |
190,000
| – | – | 0.25% | 71 |
|
|
2023
Q1 | $3.02M | Sell |
190,000
-10,000
| -5% | -$159K | 0.33% | 69 |
|
|
2022
Q4 | $2.99M | Buy |
+200,000
| New | +$2.99M | 0.31% | 73 |
|